Sector | Healthcare | Compare with Sector peers |
Industry | Hospital & Healthcare Services | Compare with Industry peers |
Website | http://www.drhlsl.com | |
Market Cap | 24.95 Cr. | |
Enterprise Value(EV) | 27.12 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.48 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-03 |
Industry PE | 66.57 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 8.45 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 1.99 | Calculated using Price: 16.85 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.48 Cr. | 14,808,706 Shares |
FaceValue | 10 | |
About Samsrita Labs Ltd. | ||
Dr Habeebullah Life Sciences with its group Companies has established platforms in the areas of Stem Cell Research and Therapy, New Drug Discovery, Molecular Prognosis and Diagnostics services, CRO, Stem Cell focused Super Specialty Hospital, RNA Interference Technology and Medical Devices. |
1 Day |
|
+1.14% |
1 Week |
|
+4.79% |
1 Month |
|
+20.36% |
3 Month |
|
-3.71% |
6 Month |
|
+0.18% |
1 Year |
|
-15.71% |
2 Year |
|
-36.77% |
5 Year |
|
-44.57% |
10 Year |
|
7 years | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -16.62 | -11.85 | -21.62 | -16.88 | -6.71 | 12.29 | -5.48 | |
Return on Capital Employed (%) | -4.07 | -6.81 | -12.27 | -10.1 | -4.53 | 10.2 | -4.61 | |
Return on Assets (%) | -6.9 | -5.06 | -9.63 | -7.4 | -3.47 | 8.89 | -4.32 |
Particulars | 7 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Shh. Funds | 8 | 11 | 12 | 12 | 11 | 13 | 13 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Curr. Liab. | 7 | 7 | 10 | 12 | 5 | 4 | 3 | |
Minority Int. | 4 | 4 | 4 | 4 | ||||
Equity & Liab. | 19 | 23 | 26 | 28 | 17 | 17 | 16 | |
Non Curr. Assets | 16 | 18 | 20 | 21 | 10 | 10 | 10 | |
Curr. Assets | 3 | 4 | 6 | 7 | 7 | 7 | 6 | |
Misc. Exp. not W/O | ||||||||
Total Assets | 19 | 23 | 26 | 28 | 17 | 17 | 16 |
Particulars | 8 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2021-09 Rs. Cr. TTM | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Net Sales | 1 | 1 | 2 | 1 | 0 | 0 | 0 | ||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | |
Total Income | 1 | 1 | 2 | 2 | 0 | 0 | 2 | 0 | |
Total Expenditure | -2 | -2 | -4 | -4 | -1 | 0 | 0 | -1 | |
PBIDT | -1 | -1 | -2 | -2 | -1 | 0 | 2 | -1 | |
Interest | 0 | 0 | |||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Taxation | -1 | 0 | 0 | 0 | 0 | ||||
Exceptional Items | |||||||||
PAT | -1 | -1 | -2 | -2 | -1 | 0 | 2 | -1 | |
Minority Interest | 0 | 0 | 0 | 0 | |||||
Share Associate | 0 | ||||||||
Other Related Items | |||||||||
Consolidated Net Profit | -1 | -1 | -2 | -2 | -1 | 0 | 1 | -1 | |
Adjusted EPS | -1 | -1 | -2 | -1 | -1 | 0 | 1 | 0 |
Particulars | 7 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | -3 | -3 | -1 | 0 | 0 | 1 | |
Cash Fr. Inv. | -1 | -1 | -2 | -1 | 0 | |||
Cash Fr. Finan. | 1 | 5 | 4 | 2 | 1 | 0 | -1 | |
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 |
Tue, 16 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under reg. 74(5) of SEBI (DP) Regulations 2018 |
Sat, 30 Mar 2024
Closure of Trading Window Closure of Trading Window |
Wed, 21 Feb 2024
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on February 21 2024 for Krishnam Raju Kalidindi |
Fri, 19 Apr 2024 |
High Delivery Percentage |
Opening at High |
High Increase in 1 Month |
CCI Overbought Zone |
Hanging Man |